COVID-19 Testing Resource Center

Topic highlights include: White House launches monkeypox research agenda, Mayo Clinic: collaborations, startups to drive innovation, Why the latest screening tests and treatments offer hope for ovarian cancer

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss the Saving Access to Laboratory Services Act (SALSA), how it is designed to mitigate harmful effects of the Protecting Access to Medicare Act (PAMA), where the legislation stands today, and how to get involved in advocacy.

Connie Ohnstad is the supervisor for Mayo Clinic Laboratories Inventory, which includes Mayo Clinic Laboratories Packaging and Specimen Kit Orders (SKO). Connie wears many hats as a supervisor at MCL, and she has a long history with Mayo Clinic, which has employed several generations of Connie’s family. She takes pride in ensuring that every day she offers her best for her employees, patients, and clients.

This week's research roundup features: Into the future: a pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer

Katherine Geiersbach, M.D., explains how Mayo Clinic Laboratories' PIK3CA assay informs breast cancer treatment. The assay identifies patients eligible for a certain second-line therapy when initial treatment has failed.

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, they discuss Dr. Morice’s new role as CEO and president of Mayo Clinic Laboratories (MCL), his patient-centered vision for the future, and how MCL is leading positive changes in the diagnostics industry.

By collaborating with Mayo Clinic Laboratories, Morris Hospital & Healthcare Center has been able to expand complex and specialized lab testing in the communities they serve.

Topic highlights include: Mayo Clinic health system experts say mental health issues on the rise, New York declares a state of emergency over polio, U.S. reaches medical milestone with millionth organ transplant

Advice for Medical Students Matching Into Pathology

Lab Medicine Rounds

In this episode of “Lab Medicine Rounds,” [...]

Joseph Maleszewksi, M.D., and Marie-Christine Aubry, M.D., explain how Mayo Clinic Laboratory can provide definitive diagnosis of primary ciliary dyskinesia (PCD). Mayo Clinic's expertise and technology have earned the laboratory's designation as the sole center of excellence for diagnosing this rare respiratory disorder.

In Mayo Clinic’s Advanced Diagnostics Laboratory, there are dozens of projects underway at once to develop new technologies, discover novel findings, validate new tests, and support physicians in providing advanced patient care. For example, researchers are using phage immunoprecipitation sequencing (PhIP-Seq) to discover new serological biomarkers for autoimmune diseases. In a recent study using PhIP-Seq, Mayo Clinic researchers discovered a previously unknown antibody marker for immune-mediated rippling muscle disease (iRMD). This finding will support testing options and accurate diagnosis of iRMD, helping physicians treat patients with iRMD and restore their quality of life.

This week's research roundup features: A simple score to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction